Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Ulcerative Colitis | Research

Behavioral abnormalities in C57BL/6 mice with chronic ulcerative colitis induced by DSS

Authors: Yuxin Zhou, Gang Ji, Xiaoyi Yang, Zhenhua Chen, Liangliang Zhou

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Background

Clinical epidemiological studies have found that some patients with ulcerative colitis (UC) are prone to mental disorders. DSS-induced acute and chronic UC models are often used to evaluate the efficacy of anti-UC drugs. However, whether DSS has an effect on mouse behavior has not been reported.

Methods

Acute and chronic UC models were induced by 3% DSS and 1.5% DSS, respectively. The bloody stool, the changes in the colon length, and histopathological changes in the colon were used to evaluate the success of the animal model. The behavior of mice was evaluated by open field experiment, tail suspension experiment and Sucrose preference test.

Results

The weight of mice in 3% DSS group decreased significantly, the DAI score increased significantly, the colon length of mice was significantly shortened, and the structure of colonic crypts was abnormal, which showed inflammatory cell infiltration and shrinkage of crypts. Compared with the control group, the immobility time of 3%DSS group mice in the tail suspension test and forced swimming test had no effect, the number of running and grooming times was significantly reduced, and there was no significant difference in the number of standing times. No abnormality was observed in HE staining of the hippocampus. However, in 1.5% DSS-induced chronic UC model, behavioral and hippocampal abnormalities were observed not only UC symptoms.

Conclusions

The acute UC model induced by 3% DSS has certain influence on the behavior of mice, but the mental state of mice is normal, which may be the abnormal behavior caused by UC symptoms; However, the chronic UC model induced by 1.5% DSS has a significant effect on the behavior of mice, and the mice have mental disorders, which are caused by mental disorders.
Literature
1.
2.
3.
go back to reference Zhang L, Gan HT. Secondary colon cancer in patients with ulcerative colitis: a systematic review and meta-analysis. J Gastrointest Oncol. 2021;12(6):2882–90.CrossRefPubMedPubMedCentral Zhang L, Gan HT. Secondary colon cancer in patients with ulcerative colitis: a systematic review and meta-analysis. J Gastrointest Oncol. 2021;12(6):2882–90.CrossRefPubMedPubMedCentral
4.
go back to reference Du LL, Ha C. Epidemiology and Pathogenesis of Ulcerative Colitis. Gastroenterol Clin North Am. 2020;49(4):643–54. Du LL, Ha C. Epidemiology and Pathogenesis of Ulcerative Colitis. Gastroenterol Clin North Am. 2020;49(4):643–54.
5.
go back to reference Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–78.CrossRefPubMed Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–78.CrossRefPubMed
6.
go back to reference Di Sabatino A, Biancheri P, Rovedatti L, et al. Recent advances in understanding ulcerative colitis. Intern Emerg Med. 2012;7(2):103–11.CrossRefPubMed Di Sabatino A, Biancheri P, Rovedatti L, et al. Recent advances in understanding ulcerative colitis. Intern Emerg Med. 2012;7(2):103–11.CrossRefPubMed
9.
go back to reference Sharifi A, Vahedi H, Nedjat S, et al. Vitamin D Decreases Beck Depression Inventory Score in Patients with Mild to Moderate Ulcerative Colitis: A Double-Blind Randomized Placebo-Controlled Trial. J Diet Suppl. 2019;16(5):541–9.CrossRefPubMed Sharifi A, Vahedi H, Nedjat S, et al. Vitamin D Decreases Beck Depression Inventory Score in Patients with Mild to Moderate Ulcerative Colitis: A Double-Blind Randomized Placebo-Controlled Trial. J Diet Suppl. 2019;16(5):541–9.CrossRefPubMed
10.
go back to reference Neuendorf R, Harding A, Stello N, et al. Depression and anxiety in patients with Inflammatory Bowel Disease: A systematic review. J Psychosom Res. 2016;87:70–80.CrossRefPubMed Neuendorf R, Harding A, Stello N, et al. Depression and anxiety in patients with Inflammatory Bowel Disease: A systematic review. J Psychosom Res. 2016;87:70–80.CrossRefPubMed
11.
go back to reference Wilkinson B, Trick L, Knight A, et al. Factors associated with depression in people with inflammatory bowel disease: The relationship between active disease and biases in neurocognitive processing. Neurogastroenterol Motil. 2019;31(8):11.CrossRef Wilkinson B, Trick L, Knight A, et al. Factors associated with depression in people with inflammatory bowel disease: The relationship between active disease and biases in neurocognitive processing. Neurogastroenterol Motil. 2019;31(8):11.CrossRef
12.
go back to reference Frolkis AD, Vallerand IA, Shaheen AA, et al. Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression. Gut. 2019;68(9):1606–12.CrossRefPubMed Frolkis AD, Vallerand IA, Shaheen AA, et al. Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression. Gut. 2019;68(9):1606–12.CrossRefPubMed
13.
go back to reference Silva I, Pinto R, Mateus V. Preclinical Study in Vivo for New Pharmacological Approaches in Inflammatory Bowel Disease: A Systematic Review of Chronic Model of TNBS-Induced Colitis. J Clin Med. 2019;8(10):20.CrossRef Silva I, Pinto R, Mateus V. Preclinical Study in Vivo for New Pharmacological Approaches in Inflammatory Bowel Disease: A Systematic Review of Chronic Model of TNBS-Induced Colitis. J Clin Med. 2019;8(10):20.CrossRef
14.
go back to reference Leonardi I, Nicholls F, Atrott K, et al. Oral administration of dextran sodium sulphate induces a caecum-localized colitis in rabbits. Int J Exp Pathol. 2015;96(3):151–62.CrossRefPubMedPubMedCentral Leonardi I, Nicholls F, Atrott K, et al. Oral administration of dextran sodium sulphate induces a caecum-localized colitis in rabbits. Int J Exp Pathol. 2015;96(3):151–62.CrossRefPubMedPubMedCentral
15.
go back to reference Randhawa PK, Singh K, Singh N, et al. A Review on Chemical-Induced Inflammatory Bowel Disease Models in Rodents. Korean J Physiol Pharmacol. 2014;18(4):279–88.CrossRefPubMedPubMedCentral Randhawa PK, Singh K, Singh N, et al. A Review on Chemical-Induced Inflammatory Bowel Disease Models in Rodents. Korean J Physiol Pharmacol. 2014;18(4):279–88.CrossRefPubMedPubMedCentral
16.
go back to reference Lan P, Ting W, Qian L, et al. Protective role of ergothioneine isolated from Pleurotus ostreatus against dextran sulfate sodium-inducederative colitis in rat model. J Food Sci. 2021;87(1):415–26. Lan P, Ting W, Qian L, et al. Protective role of ergothioneine isolated from Pleurotus ostreatus against dextran sulfate sodium-inducederative colitis in rat model. J Food Sci. 2021;87(1):415–26.
17.
19.
go back to reference Gancarcikova S, Lauko S, Hrckova G, et al. Innovative Animal Model of DSS-Induced Ulcerative Colitis in Pseudo Germ-Free Mice. Cells. 2020;9(12):28.CrossRef Gancarcikova S, Lauko S, Hrckova G, et al. Innovative Animal Model of DSS-Induced Ulcerative Colitis in Pseudo Germ-Free Mice. Cells. 2020;9(12):28.CrossRef
20.
21.
go back to reference Liu MY, Yin CY, Zhu LJ, et al. Sucrose preference test for measurement of stress-induced anhedonia in mice. Nat Protoc. 2018;13(7):1686–98.CrossRefPubMed Liu MY, Yin CY, Zhu LJ, et al. Sucrose preference test for measurement of stress-induced anhedonia in mice. Nat Protoc. 2018;13(7):1686–98.CrossRefPubMed
22.
go back to reference Luan ZJ, Li Y, Zhao XY, et al. Treatment efficacy and safety of low-dose azathioprine in chronic active ulcerative colitis patients: A meta-analysis and systemic review. J Dig Dis. 2016;17(10):652–9.CrossRefPubMed Luan ZJ, Li Y, Zhao XY, et al. Treatment efficacy and safety of low-dose azathioprine in chronic active ulcerative colitis patients: A meta-analysis and systemic review. J Dig Dis. 2016;17(10):652–9.CrossRefPubMed
23.
go back to reference Shieh KR, Yang SC. Formosan wood mice (Apodemus semotus) exhibit more exploratory behaviors and central dopaminergic activities than C57BL/6 mice in the open field test. Chin J Physiol. 2020;63(1):27–34.CrossRefPubMed Shieh KR, Yang SC. Formosan wood mice (Apodemus semotus) exhibit more exploratory behaviors and central dopaminergic activities than C57BL/6 mice in the open field test. Chin J Physiol. 2020;63(1):27–34.CrossRefPubMed
24.
go back to reference Stukalin Y, Lan A, Einat H. Revisiting the validity of the mouse tail suspension test: Systematic review and meta-analysis of the effects of prototypic antidepressants. Neurosci Biobehav Rev. 2020;112:39–47.CrossRefPubMed Stukalin Y, Lan A, Einat H. Revisiting the validity of the mouse tail suspension test: Systematic review and meta-analysis of the effects of prototypic antidepressants. Neurosci Biobehav Rev. 2020;112:39–47.CrossRefPubMed
25.
go back to reference Fonseca-Rodrigues D, Goncalves J, Laranjeira I, et al. Sucrose intake and preference by Wistar Han rats are not influenced by sex or food/water deprivation. Pharmacol Biochem Behav. 2022;216:173387.CrossRefPubMed Fonseca-Rodrigues D, Goncalves J, Laranjeira I, et al. Sucrose intake and preference by Wistar Han rats are not influenced by sex or food/water deprivation. Pharmacol Biochem Behav. 2022;216:173387.CrossRefPubMed
26.
go back to reference Rubin DT, Ananthakrishnan AN, Siegel CA, et al. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019;114(3):384–413.CrossRefPubMed Rubin DT, Ananthakrishnan AN, Siegel CA, et al. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019;114(3):384–413.CrossRefPubMed
27.
go back to reference Raine T, Bonovas S, Burisch J, et al. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment. J Crohns Colitis. 2022;16(1):2–17.CrossRefPubMed Raine T, Bonovas S, Burisch J, et al. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment. J Crohns Colitis. 2022;16(1):2–17.CrossRefPubMed
28.
go back to reference Jimenez JLD, Garcia EMP, Herrera RC. Mesalazine-induced acute hepatitis. Gastroenterol Hepatol. 2015;38(4):302–3. Jimenez JLD, Garcia EMP, Herrera RC. Mesalazine-induced acute hepatitis. Gastroenterol Hepatol. 2015;38(4):302–3.
29.
go back to reference Berends SE, Strik AS, Lowenberg M, et al. Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis. Clin Pharmacokinet. 2019;58(1):15–37.CrossRefPubMed Berends SE, Strik AS, Lowenberg M, et al. Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis. Clin Pharmacokinet. 2019;58(1):15–37.CrossRefPubMed
30.
go back to reference Gao X, Tang Y, Lei N, et al. Symptoms of anxiety/depression is associated with more aggressive inflammatory bowel disease. Sci Rep. 2021;11(1):7. Gao X, Tang Y, Lei N, et al. Symptoms of anxiety/depression is associated with more aggressive inflammatory bowel disease. Sci Rep. 2021;11(1):7.
31.
go back to reference Xu HM, Huang HL, Liu YD, et al. Selection strategy of dextran sulfate sodium-induced acute or chronic colitis mouse models based on gut microbial profile. BMC Microbiol. 2021;21(1):14.CrossRef Xu HM, Huang HL, Liu YD, et al. Selection strategy of dextran sulfate sodium-induced acute or chronic colitis mouse models based on gut microbial profile. BMC Microbiol. 2021;21(1):14.CrossRef
32.
go back to reference Mikocka-Walus A, Prady SL, Pollok J, et al. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease. Cochrane Database Syst Rev. 2019;4:55. Mikocka-Walus A, Prady SL, Pollok J, et al. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease. Cochrane Database Syst Rev. 2019;4:55.
33.
go back to reference Vakhitova YV, Kuzmina US, Voronin MV, et al. Effect of Fabomotizole on Brain Gene Expression in MR Rats in the Open Field Test. Dokl Biochem Biophys. 2019;488(1):313–5.CrossRefPubMed Vakhitova YV, Kuzmina US, Voronin MV, et al. Effect of Fabomotizole on Brain Gene Expression in MR Rats in the Open Field Test. Dokl Biochem Biophys. 2019;488(1):313–5.CrossRefPubMed
34.
go back to reference Koek W, Sandoval TL, Daws LC. Effects of the antidepressants desipramine and fluvoxamine on latency to immobility and duration of immobility in the forced swim test in adult male C57BL/6J mice. Behav Pharmacol. 2018;29(5):453–6.CrossRefPubMedPubMedCentral Koek W, Sandoval TL, Daws LC. Effects of the antidepressants desipramine and fluvoxamine on latency to immobility and duration of immobility in the forced swim test in adult male C57BL/6J mice. Behav Pharmacol. 2018;29(5):453–6.CrossRefPubMedPubMedCentral
35.
go back to reference Kawai H, Iwadate R, Ishibashi T, et al. Antidepressants with different mechanisms of action show different chronopharmacological profiles in the tail suspension test in mice. Chronobiol Int. 2019;36(9):1194–207.CrossRefPubMed Kawai H, Iwadate R, Ishibashi T, et al. Antidepressants with different mechanisms of action show different chronopharmacological profiles in the tail suspension test in mice. Chronobiol Int. 2019;36(9):1194–207.CrossRefPubMed
Metadata
Title
Behavioral abnormalities in C57BL/6 mice with chronic ulcerative colitis induced by DSS
Authors
Yuxin Zhou
Gang Ji
Xiaoyi Yang
Zhenhua Chen
Liangliang Zhou
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02718-2

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.